217 related articles for article (PubMed ID: 8915309)
1. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities.
Callot V; Roujeau JC; Bagot M; Wechsler J; Chosidow O; Souteyrand P; Morel P; Dubertret L; Avril MF; Revuz J
Arch Dermatol; 1996 Nov; 132(11):1315-21. PubMed ID: 8915309
[TBL] [Abstract][Full Text] [Related]
2. [Misleading or rare cutaneous drug reactions].
Souteyrand P; d'Incan M; Parent S
Rev Prat; 2000 Jun; 50(12):1329-33. PubMed ID: 10972075
[TBL] [Abstract][Full Text] [Related]
3. [Febrile toxiderma in children].
Larrègue M; Vabres P; Auriol F
Rev Prat; 1997 Sep; 47(13):1452-7. PubMed ID: 9339026
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).
Bocquet H; Bagot M; Roujeau JC
Semin Cutan Med Surg; 1996 Dec; 15(4):250-7. PubMed ID: 9069593
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous pseudolymphoma caused by carbamazepine].
d'Incan M; Mouillet ML; Roger H; Ferrier MC; Buono JP; Déchelotte P; Bignon YJ; Souteyrand P
Ann Dermatol Venereol; 1998 Jan; 125(1):52-5. PubMed ID: 9747211
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic infiltration of the skin (Jessner-Kanof) but not reticular erythematous mucinosis occasionally represents clinical manifestations of Borrelia-associated pseudolymphoma.
Ziemer M; Eisendle K; Müller H; Zelger B
Br J Dermatol; 2009 Sep; 161(3):583-90. PubMed ID: 19486001
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
8. [Drug hypersensitive syndrome caused by fluindione].
Sparsa A; Bédane C; Benazahary H; De Vencay P; Gauthier ML; Le Brun V; Boulinguez S; Loustaud-Ratti V; Soria P; Vidal E; Bonnetblanc JM
Ann Dermatol Venereol; 2001 Oct; 128(10 Pt 1):1014-8. PubMed ID: 11907960
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients.
Segura S; Pujol RM; Trindade F; Requena L
J Am Acad Dermatol; 2008 Nov; 59(5):839-51. PubMed ID: 19119100
[TBL] [Abstract][Full Text] [Related]
10. Bronchiolitis obliterans-organizing pneumonia: an Italian experience.
Cazzato S; Zompatori M; Baruzzi G; Schiattone ML; Burzi M; Rossi A; Ratta L; Terzuolo G; Falcone F; Poletti V
Respir Med; 2000 Jul; 94(7):702-8. PubMed ID: 10926343
[TBL] [Abstract][Full Text] [Related]
11. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis.
Bahrami S; Malone JC; Webb KG; Callen JP
Arch Dermatol; 2006 Feb; 142(2):155-61. PubMed ID: 16490843
[TBL] [Abstract][Full Text] [Related]
12. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?
Häusermann P; Harr T; Bircher AJ
Contact Dermatitis; 2004; 51(5-6):297-310. PubMed ID: 15606657
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of skin testing in cutaneous drug eruptions in routine practice.
Tchen T; Reguiaï Z; Vitry F; Arnoult E; Grange A; Florent G; Bernard P
Contact Dermatitis; 2009 Sep; 61(3):138-44. PubMed ID: 19780771
[TBL] [Abstract][Full Text] [Related]
14. Lymphomatoid drug reaction secondary to methylphenidate hydrochloride.
Welsh JP; Ko C; Hsu WT
Cutis; 2008 Jan; 81(1):61-4. PubMed ID: 18306850
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous pseudolymphoma induced by Cimicifuga racemosa.
Meyer S; Vogt T; Obermann EC; Landthaler M; Karrer S
Dermatology; 2007; 214(1):94-6. PubMed ID: 17191056
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo].
Gardair Bouchy C; Kerdraon R; Kluger N; Armingaud P; Wakosa A; Estève E
Ann Pathol; 2013 Aug; 33(4):273-7. PubMed ID: 23954123
[TBL] [Abstract][Full Text] [Related]
17. Drug eruptions: approaching the diagnosis of drug-induced skin diseases.
Nigen S; Knowles SR; Shear NH
J Drugs Dermatol; 2003 Jun; 2(3):278-99. PubMed ID: 12848112
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine-induced pseudolymphoma with CD-30 positive cells.
Nathan DL; Belsito DV
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):806-9. PubMed ID: 9591791
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous lymphoid hyperplasia and reactive lymphadenopathy induced by hepatitis B vaccination.
Atalar H; Sarifakioglu E; Dener C; Yanik B; Koktener A; Bayrak R
Eur J Dermatol; 2008; 18(2):188-9. PubMed ID: 18424381
[No Abstract] [Full Text] [Related]
20. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
